Lineage, Inc. Common Stock (LINE)vsUcommune International Ltd (UK)
LINE
Lineage, Inc. Common Stock
$37.52
+1.93%
REAL ESTATE · Cap: $9.41B
UK
Ucommune International Ltd
$2.10
+10.89%
REAL ESTATE · Cap: $7.31M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 20463% more annual revenue ($5.37B vs $26.12M). LINE leads profitability with a -3.1% profit margin vs -144.9%. LINE earns a higher WallStSmart Score of 35/100 (F).
LINE
Avoid35
out of 100
Grade: F
UK
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
-79.0%
Fair Value
$0.27
Current Price
$2.10
$1.83 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Reasonable price relative to book value
Conservative balance sheet, low leverage
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -40.6% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : UK
The strongest argument for UK centers on Price/Book, Debt/Equity.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : UK
The primary concerns for UK are EPS Growth, Market Cap, Piotroski F-Score.
Key Dynamics to Monitor
LINE carries more volatility with a beta of 0.88 — expect wider price swings.
LINE is growing revenue faster at 0.8% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Monitor REIT - INDUSTRIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
LINE scores higher overall (35/100 vs 31/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Ucommune International Ltd
REAL ESTATE · REAL ESTATE SERVICES · China
Ucommune International Ltd provides and manages agile office spaces in China and internationally. The company is headquartered in Beijing, China.
Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?